6-anilino-5,8-quinolinedione has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies
6-anilino-5,8-quinolinedione: structure given in first source; SRS-A & guanylate cyclase antagonist
6-anilino-5,8-quinolinedione : A quinolone that is quinoline-5,8-dione in which the hydrogen at position 6 is replaced by an anilino group.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayrak, N | 1 |
| Ciftci, HI | 1 |
| Yıldız, M | 1 |
| Yıldırım, H | 1 |
| Sever, B | 1 |
| Tateishi, H | 1 |
| Otsuka, M | 1 |
| Fujita, M | 1 |
| Tuyun, AF | 1 |
1 other study available for 6-anilino-5,8-quinolinedione and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Structure based design, synthesis, and evaluation of anti-CML activity of the quinolinequinones as LY83583 analogs.
Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chemistry Techniques, Synthetic | 2021 |